Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice
- 1 February 1998
- journal article
- Published by Elsevier in Brain Research
- Vol. 783 (1) , 109-114
- https://doi.org/10.1016/s0006-8993(97)01192-x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Biochemical, physiological and medical aspects of ubiquinone functionPublished by Elsevier ,1999
- Intrastriatal injection of GDNF attenuates the effects of 6-hydroxydopamineNeuroReport, 1996
- Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicityExperimental Neurology, 1995
- Oxidative stress in Parkinson's diseaseNeuropathology and Applied Neurobiology, 1995
- Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromesBrain, 1993
- A radical hypothesis for neurodegenerationTrends in Neurosciences, 1993
- Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson's DiseaseJournal of Neurochemistry, 1990
- MPTP treatment combined with ethanol or acetaldehyde selectively destroys dopaminergic neurons in mouse substantia nigraBrain Research, 1989
- Telencephalic Projections of the A8 Dopamine Cell GroupAnnals of the New York Academy of Sciences, 1988
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983